Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder

Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies

(2018) Kyle J. Burghardt et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

(2017) Christoph U. Correll et al.   World Psychiatry

Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance

(2016) Kyle J Burghardt et al.   BIPOLAR DISORDERS

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

(2016) Davy Vancampfort et al.   World Psychiatry

The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia

(2015) Stefania Bonaccorso et al.   BIPOLAR DISORDERS

An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder

(2015) Kyle J. Burghardt et al.   CTS-Clinical and Translational Science

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Increased Interaction With Insulin Receptor Substrate 1, a Novel Abnormality in Insulin Resistance and Type 2 Diabetes

(2014) Michael Caruso et al.   DIABETES

The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect

(2014) G. C. Smith et al.   PSYCHOPHARMACOLOGY

Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators

(2013) Davy Vancampfort et al.   AMERICAN JOURNAL OF PSYCHIATRY

Pharmacogenomics of sterol synthesis and statin use in schizophrenia subjects treated with antipsychotics

(2013) Thomas J Vassas et al.   PHARMACOGENOMICS

Comparison Study of MS-HRM and Pyrosequencing Techniques for Quantification of APC and CDKN2A Gene Methylation

(2013) Francesca Migheli et al.   PLoS One

Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries

(2013) Thomas Munk Laursen et al.   PLoS One

Defining Akt actions in muscle differentiation

(2012) Samantha Gardner et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Dopamine D2 Receptor-Mediated AKT/PKB Signalling: Initiation by the D2S Receptor and Role in Quinpirole-Induced Behavioural Activation

(2012) Han-Ting Chen et al.   ASN Neuro

The possible role of the Akt signaling pathway in schizophrenia

(2012) Wenhua Zheng et al.   BRAIN RESEARCH

The Akt kinases: Isoform specificity in metabolism and cancer

(2011) Eva Gonzalez et al.   CELL CYCLE

Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets

(2011) Mao-Liang Chen et al.   IMMUNOLOGY LETTERS

A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health

(2011) Jean-Martin Beaulieu   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Pathogenesis of Insulin Resistance in Skeletal Muscle

(2010) Muhammad A. Abdul-Ghani et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance

(2009) Hui-Yu Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action

(2009) Zachary Freyberg et al.   AMERICAN JOURNAL OF PSYCHIATRY

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

(2009) R. A. DeFronzo et al.   DIABETES CARE

Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation

(2009) Peter Rotwein et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Methylation-sensitive high-resolution melting

(2009) Tomasz K Wojdacz et al.   Nature Protocols

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

(2009) Jean-Michel Aubry et al.   PSYCHOPHARMACOLOGY

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

(2008) Christoph U Correll et al.   BIPOLAR DISORDERS